Ticker
TRVICompany Name
TREVI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 208.34M | $ 117.06M | 56.19% |
3/31/2025 | $ 107M | $ 19.37M | 18.11% |
12/31/2024 | $ 110.9M | $ 34.1M | 30.75% |
9/30/2024 | $ 68.91M | $ 16.05M | 23.29% |
6/30/2024 | $ 73.81M | $ 12.96M | 17.56% |
3/31/2024 | $ 78.56M | $ 13.81M | 17.58% |
12/31/2023 | $ 89.4M | $ 32.4M | 36.24% |
9/30/2023 | $ 95.9M | $ 25.96M | 27.08% |
6/30/2023 | $ 100.98M | $ 13.75M | 13.62% |
3/31/2023 | $ 116.2M | $ 11.65M | 10.03% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for TREVI THERAPEUTICS INC is calculated as follows: CashnEq [ $ 53.29M ] / Assets [ $ 55.88M ]
(=) Cash to Assets [ 95.37% ]
Minimum
Mar 31, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |